RS-Glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model

Maria Galuppo, Sabrina Giacoppo, Gina Rosalinda De Nicola, Renato Iori, Emanuela Mazzon, Placido Bramanti

Research output: Contribution to journalArticle

Abstract

Spinal cord injury (SCI) is a highly debilitating pathology. Although innovative medical care has been improved, drug therapies to counteract neuronal damage and promote regeneration are limited. An experimental mouse model of SCI was designed to examine the possible neuroprotective role of the glucosinolate (RS)-glucoraphanin (RS-GRA), bioactivated with myrosinase enzyme (MYR-activated RS-GRA). Methodologically, the injury was induced by application of an aneurysm clip (force of 24g) for 1 min via four-level T5-T8 after laminectomy. MYR-activated RS-GRA was administered in mice (10 mg/kg i.p.) 1 and 6 h after the trauma, identified as the therapeutic intervention window. The treatment with MYR-activated R S-GRA significantly decreased histological damage resulted by proinflammatory events as well as by apoptosis cascade. Overall, by quantitative analysis of immunohistochemical images, the neuroprotection has been quite evident. MYR-activated RS-GRA has given a histological quantification around zero in all determinations. Particularly, looking at the strongest data obtained, regarding the glial fibrillary acidic protein (GFAP), result the high tissue localization of this damage marker mediated by astrocyte activity, estimated as about 80% of positive staining, was shot down by MYR-activated RS-GRA treatment. Taken together, our results show that MYR-activated RS-GRA could represent an interesting approach for the management of secondary damage following SCI.

Original languageEnglish
Pages (from-to)88-96
Number of pages9
JournalJournal of the Neurological Sciences
Volume334
Issue number1-2
DOIs
Publication statusPublished - Nov 15 2013

Keywords

  • Apoptosis
  • Bioactive (R)-glucoraphanin
  • Inflammation
  • Myrosinase enzyme
  • Proinflammatory cytokines
  • Spinal cord injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint Dive into the research topics of 'RS-Glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model'. Together they form a unique fingerprint.

  • Cite this